Restek Releases the First Standard to Contain all Major PAH Interferences

Chromatography

Restek Releases the First Standard to Contain all Major PAH Interferences

26 Oct, 2015

Published over 10 years ago. See the latest and most current information on Chromatography.

The new PAH interferences standard from Restek is the first and only certified reference material formulated to contain all major PAH interferences for priority PAHs. Analysts can use this mixture to quickly confirm the presence of common interferences by retention time comparisons. Since the PAH components are present in different concentrations, isomers can easily be distinguished by the difference in their response factors. Several key PAHs of health concern—such as chrysene and benzo[b]fluoranthene—coelute with other PAHs on most GC columns, which biases results. To ensure accurate reporting, this standard can be paired with an Rxi®-PAH column and Restek’s EU 15+1 PAH standard to optimise method conditions and ensure separation of interferences and target PAHs. As this new PAH interferences standard meets strict ISO quality requirements, it is also suitable for quantitative work as a calibration or fortification standard.

PAH Interferences Standard 250–1,000 μg/mL, Toluene, 1 mL/ampul            Cat.# 32472 ($50 US List)

Compound CAS#

Concentration (μg/mL)

Benzo[k]fluoranthene 207-08-9 1,000
Benzo[j]fluoranthene 205-82-3 750
Triphenylene 217-59-4 750
Benzo[e]pyrene 192-97-2 500
Perylene 198-55-0 250

www.restek.com/PAHinterferences

Latest News

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Measurement to mitigation in the next evolution of emissions monitoring
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
Fifty years on, the EU reaffirms its commitment to Seveso-level industrial safety oversight
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow